Tag Archives: social media

Facts Not Fiction: Digital Delivers Results for Biotech Companies

Digital Ad panel at BIO 2016

A panel of experts in the digital advertising space assembled Wednesday at the 2016 BIO International Convention to discuss how biotech companies can utilize digital advertising in their overall marketing strategies. The session was moderated by Julie Papanek, (Principal, Canaan Partners), and the panelists were: Craig Hashi, Ph.D. (Health, Facebook), Matthew Howes (Executive Vice President, Strategy & Growth, PALIO, an inVentiv Health company), Will Springgate (Director, Life Sciences Allscripts), and Wister Walcott (Co-Founder; Lead Consultant, Marin Software; Proxita). The Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Nasdaq Social Bell: Twitter Strategies For Biotechs

Nasdaq Social Bell

Last week at the BIO CEO & Investor Conference in New York City, I had the pleasure of speaking with John Machiz and Brad Smith from Nasdaq at their headquarters in Times Square to discuss the social media activity that happened onsite during the event, what made the discussion of the event online so robust, and what biotech companies can do to increase their visibility on Twitter. View the video below, and get a recap of the Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Liking, Sharing, and Tweeting to Better Health

BIO2014 Panel

Making an impact online goes beyond having a Facebook page. Helping to open the 2014 BIO International Convention, Amy O’Conner, Director, Digital Government Affairs with Eli Lilly and Company, joined Chief Marketing Officer at POPVOX, Rachna Choudhry; Twitter’s Head of Healthcare, Jeremy Anderson; and Chief Strategist at Pure Communications, Mike Huckman, to discuss how social media can empower individuals and patient advocates to improve the future of health care. O’Conner writes: “Part of what makes Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

#BIOBuyside Twitter Chat: What Do Biotech Investors Expect in 2014?

Dave Thomas

Is 2014 a good time to invest in biotech? How many biotech IPOs will there be? Which sectors will perform the best? To find out what investors think about these questions and more, BIO is conducting its annual Buy-side Investor Perception Survey and releasing the results at the 16th Annual BIO CEO & Investor Conference in New York, Monday Feb. 10. But as the results are coming in, BIO is hosting the #BIOBuyside Twitter chat Read More >

Inside BIO Industry Analysis  |  2 Comments  |  Email This Post
Tags: , , , , , , , , , ,

Involving Patients in the Research Process

PsAM-2013-Facebook-Shareable115x76

According to the National Psoriasis Foundation, as many as 7.5 million Americans live with psoriasis, making it the most common autoimmune disease in the country. More than just a skin condition, psoriasis puts people at increased risk for other serious diseases such as heart disease, diabetes and depression. Up to 30 percent of people with psoriasis develop psoriatic arthritis, an inflammatory joint disease. A complex disease with a genetic component, psoriasis is not contagious. While Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,